UKpolicy

Market Access

US currency with injection needles and pills on top, against orange background

US pharma MFN and tariff dynamics: What EU and UK leaders ne...

Europe and the United Kingdom are entering a period of direct exposure to US policy choices, and the implications are significant and immediate.

News

A globe atlas from above on a white surface

Novartis issues a life sciences warning in a 'G-Zero' world

Novartis claims life sciences lie at the centre of a shift in geopolitics and policies in regions like Europe, Japan, and Canada are "self-defeating."

Market Access

pills in the middle of a circle of pounds

Changes to UK’s VPAG: Non-submissions should be a key metric...

Whatever people think of changes to the UK’s pricing deal, VPAG, judging the difference they make should include monitoring non-submissions to NICE.

News

UK names health data chief, as BIA finds its new CEO

Dr Melanie Ivarsson has been appointed head of the UK's new Health Data Research Service, as the BIA selects Prof Chris Molloy as its new CEO.

News

JPM: Is the UK's clinical trials sector turning a corner?

New data from the UK medicines regulator has shown an increase in clinical trial activity in the country, after years of decline.

News

NICE endorses digital tools for people with asthma

Eight digital health technologies (DHTs) designed to support people with asthma can be used by the NHS in England, according to NICE.

US pharma MFN and tariff dynamics: What EU and UK leaders ne...

Novartis issues a life sciences warning in a 'G-Zero' world

Changes to UK’s VPAG: Non-submissions should be a key metric...

UK names health data chief, as BIA finds its new CEO

JPM: Is the UK's clinical trials sector turning a corner?

NICE endorses digital tools for people with asthma

Tenpoint eyes presbyopia drug launch after FDA nod

How to meet your physicians where they are online

UKpolicy

Editor's Picks